IMR Press / CEOG / Volume 42 / Issue 3 / DOI: 10.12891/ceog1836.2015

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA
Show Less
1 Department of Obstetrics and Gynecology, Beykoz State Hospital, Istanbul
2 Istanbul Bilim University, Medical Faculty, Obstetrics and Gynecology Department, Istanbul
3 Istanbul Bilim University, Medical Faculty, Medical Sciences and Genetics Department, Istanbul
4 Gayrettepe Florence Nightingale Hospital, Genetics Department, Istanbul (Turkey)
Clin. Exp. Obstet. Gynecol. 2015, 42(3), 344–346; https://doi.org/10.12891/ceog1836.2015
Published: 10 June 2015
Abstract

Objective: Anti-D immunoglobulin is applied to all pregnant women having RhD incompatibility to prevent hemolytic disease of the newborn. The aim of this study is to determine fetal RhD status in the Rh incompatible pregnancies with an non-invasive technique; free fetal DNA isolation from maternal circulation. In the case of Rh incompatibility especially with a history of previous fetal anemia, it can be beneficial to know Rh status antenatally in terms of monitoring fetuses with Rh positive [RhD(+)] status consciously. Materials and Methods: Total free DNA was isolated in 50 Rh negative [RhD(?)] pregnant women, who had RhD alloimmunisation with their husbands. The gene in isolated DNA was investigated with TagMan prob and real time PCR by using primers belonging to exon 7 of the RhD gene. Results: The authors analyzed 50 RhD(?) women by using quantitative real time PCR technique. Five of them were RhD(?) and the rest of them were found to be RhD(+). After birth one of the infants who were analyzed as RhD(+) were found to be RhD(?). Conclusion: The detection of fetal RhD status by using a non-invasive method from maternal circulation was found to be possible. Assessing fetal RhD status non-invasively by using free fetal DNA in maternal blood will be cost-efficient, avoiding unnecessary indirect Coombs test and unnecessary Rhogam applications that is used in RH incompatible pregnancies. This study will throw a fresh light on prenatal diagnosis.
Keywords
Prenatal diagnosis
Fetal DNA
RhD gene
Share
Back to top